Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04986852
Title Olinvacimab With Pembrolizumab in Patients With mTNBC
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors PharmAbcine
Indications
Therapies
Age Groups: senior | adult
Covered Countries AUS


No variant requirements are available.